Molecular Templates Stock Fundamentals
| MTEM Stock | USD 1.65 0.01 0.60% |
Molecular Templates fundamentals help investors to digest information that contributes to Molecular Templates' financial success or failures. It also enables traders to predict the movement of Molecular Stock. The fundamental analysis module provides a way to measure Molecular Templates' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molecular Templates stock.
At this time, Molecular Templates' Depreciation And Amortization is very stable compared to the past year. As of the 2nd of May 2024, Interest Expense is likely to grow to about 2.8 M, while Operating Income is likely to drop (11 M). Molecular | Select Account or Indicator |
Molecular Templates Company Return On Asset Analysis
Molecular Templates' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Molecular Templates Return On Asset | -0.0984 |
Most of Molecular Templates' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molecular Templates is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Molecular Total Assets
Total Assets |
|
Based on the latest financial disclosure, Molecular Templates has a Return On Asset of -0.0984. This is 98.88% lower than that of the Biotechnology sector and 99.58% lower than that of the Health Care industry. The return on asset for all United States stocks is 29.71% lower than that of the firm.
Molecular Templates Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Molecular Templates's current stock value. Our valuation model uses many indicators to compare Molecular Templates value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molecular Templates competition to find correlations between indicators driving Molecular Templates's intrinsic value. More Info.Molecular Templates is regarded second in return on equity category among related companies. It is regarded second in return on asset category among related companies . At this time, Molecular Templates' Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Molecular Templates by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Molecular Templates' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Molecular Templates' earnings, one of the primary drivers of an investment's value.Molecular Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecular Templates' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molecular Templates could also be used in its relative valuation, which is a method of valuing Molecular Templates by comparing valuation metrics of similar companies.Molecular Templates is currently under evaluation in return on asset category among related companies.
Molecular Templates Current Valuation Drivers
We derive many important indicators used in calculating different scores of Molecular Templates from analyzing Molecular Templates' financial statements. These drivers represent accounts that assess Molecular Templates' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Molecular Templates' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 528.4M | 447.0M | 216.8M | 18.6M | 16.8M | 16.0M | |
| Enterprise Value | 457.6M | 448.9M | 236.8M | 37.0M | 17.5M | 16.6M |
Molecular Fundamentals
| Return On Equity | -4.79 | ||||
| Return On Asset | -0.0984 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.77) % | ||||
| Current Valuation | 9.63 M | ||||
| Shares Outstanding | 6.58 M | ||||
| Shares Owned By Insiders | 3.96 % | ||||
| Shares Owned By Institutions | 58.79 % | ||||
| Number Of Shares Shorted | 205.63 K | ||||
| Price To Earning | (0.24) X | ||||
| Price To Book | 2.95 X | ||||
| Price To Sales | 0.22 X | ||||
| Revenue | 57.31 M | ||||
| Gross Profit | (45.97 M) | ||||
| EBITDA | (3.56 M) | ||||
| Net Income | (8.12 M) | ||||
| Cash And Equivalents | 104.42 M | ||||
| Cash Per Share | 1.85 X | ||||
| Total Debt | 12.23 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.40 X | ||||
| Book Value Per Share | 0.78 X | ||||
| Cash Flow From Operations | (41.82 M) | ||||
| Short Ratio | 1.28 X | ||||
| Earnings Per Share | (1.80) X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 62 | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 10.53 M | ||||
| Total Asset | 35.38 M | ||||
| Retained Earnings | (452.89 M) | ||||
| Working Capital | (549 K) | ||||
| Current Asset | 54.36 M | ||||
| Current Liabilities | 7.75 M | ||||
| Net Asset | 35.38 M |
About Molecular Templates Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecular Templates's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Templates using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Templates based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 9 M | 14.1 M | |
| Total Revenue | 57.3 M | 60.2 M | |
| Cost Of Revenue | 6.9 M | 6.6 M | |
| Stock Based Compensation To Revenue | 0.12 | 0.11 | |
| Sales General And Administrative To Revenue | 0.33 | 0.31 | |
| Research And Ddevelopement To Revenue | 0.85 | 0.81 | |
| Capex To Revenue | (0) | (0) | |
| Revenue Per Share | 12.73 | 12.09 | |
| Ebit Per Revenue | (0.18) | (0.19) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Molecular Templates in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Molecular Templates' short interest history, or implied volatility extrapolated from Molecular Templates options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Molecular Templates Piotroski F Score and Molecular Templates Altman Z Score analysis. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.Note that the Molecular Templates information on this page should be used as a complementary analysis to other Molecular Templates' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Molecular Stock analysis
When running Molecular Templates' price analysis, check to measure Molecular Templates' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Templates is operating at the current time. Most of Molecular Templates' value examination focuses on studying past and present price action to predict the probability of Molecular Templates' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Templates' price. Additionally, you may evaluate how the addition of Molecular Templates to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Molecular Templates' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 12.731 | Quarterly Revenue Growth 1.687 | Return On Assets (0.1) | Return On Equity (4.79) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.